<DOC>
	<DOC>NCT02417831</DOC>
	<brief_summary>A bio-equivalence of 2 different capsule formulations in fasted subjects</brief_summary>
	<brief_title>Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Inclusion criteria: Healthy male volunteers 18 years and older Exclusion criteria: History of hypersensitivity or allergy to the IPM or its excipients or any related medication</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>